Technology
Health
Pharmaceutical

Hoth Therapeutics

$5.10
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.10 (-1.89%) Today
-$0.10 (-1.92%) After Hours

Why Robinhood?

You can buy or sell HOTH and other stocks, options, ETFs, and crypto commission-free!

About

Hoth Therapeutics, Inc. is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. Read More It offers BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern in May 2017 and is headquartered in New York, NY.

Employees
2
Headquarters
New York, New York
Founded
2017
Market Cap
49.96M
Price-Earnings Ratio
Dividend Yield
Average Volume
20.02K
High Today
$5.71
Low Today
$5.00
Open Price
$5.71
Volume
12.74K
52 Week High
$13.88
52 Week Low
$4.41

Collections

Technology
Health
Pharmaceutical
Therapy
Biopharmaceutical
2019 IPO
US
North America

Earnings

Q1 2019
Estimated
Actual
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.